EE200400030A - Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks - Google Patents

Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks

Info

Publication number
EE200400030A
EE200400030A EEP200400030A EEP200400030A EE200400030A EE 200400030 A EE200400030 A EE 200400030A EE P200400030 A EEP200400030 A EE P200400030A EE P200400030 A EEP200400030 A EE P200400030A EE 200400030 A EE200400030 A EE 200400030A
Authority
EE
Estonia
Prior art keywords
metastasis
preventing
cancer invasion
matrix metalloproteinase
treating cancer
Prior art date
Application number
EEP200400030A
Other languages
English (en)
Inventor
Rath Matthias
Netke Shrirang
Niedzwiecki Aleksandra
Original Assignee
Rath Matthias
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rath Matthias filed Critical Rath Matthias
Publication of EE200400030A publication Critical patent/EE200400030A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EEP200400030A 2002-01-23 2003-01-23 Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks EE200400030A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35131702P 2002-01-23 2002-01-23
PCT/EP2003/000659 WO2003062413A1 (en) 2002-01-23 2003-01-23 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Publications (1)

Publication Number Publication Date
EE200400030A true EE200400030A (et) 2004-04-15

Family

ID=27613485

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200400030A EE200400030A (et) 2002-01-23 2003-01-23 Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks

Country Status (22)

Country Link
US (1) US8012935B2 (et)
EP (1) EP1468085B1 (et)
JP (1) JP2005515262A (et)
KR (1) KR20040077764A (et)
CN (2) CN1622992A (et)
AT (1) ATE425247T1 (et)
BR (1) BR0302819A (et)
CA (1) CA2472775A1 (et)
DE (1) DE60326539D1 (et)
EE (1) EE200400030A (et)
ES (1) ES2324027T3 (et)
HR (1) HRP20040732A2 (et)
IL (1) IL162714A0 (et)
LV (2) LV13289B (et)
MX (1) MXPA04007170A (et)
NO (1) NO20034146L (et)
NZ (1) NZ533738A (et)
PL (1) PL209827B1 (et)
RU (1) RU2346043C2 (et)
WO (1) WO2003062413A1 (et)
YU (1) YU76403A (et)
ZA (1) ZA200405328B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856598B1 (fr) * 2003-06-25 2005-10-28 Inst Nat Sante Rech Med Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
JP4911950B2 (ja) * 2005-11-07 2012-04-04 晃 伊東 Ｍｍｐ−１の部分ペプチドを用いた癌浸潤・転移阻害薬
CA2754635C (en) * 2009-03-06 2018-06-19 Universite Paris Descartes Use of gingival fibroblast conditioned media to treat metastatic cancer
US8593732B1 (en) * 2010-01-23 2013-11-26 Lightsmyth Technologies, Inc. Partially metallized total internal reflection immersion grating
US8003110B1 (en) * 2011-01-24 2011-08-23 Matthias W. Rath Metalloproteinase oligopeptides and their therapeutic use
EP2649985A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
US20140017267A1 (en) * 2012-07-13 2014-01-16 Matthias W Rath Metalloproteinase oligopeptides and their therapeutic use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
GB8817075D0 (en) * 1988-07-18 1988-08-24 Raychem Ltd Oscillation suppressor
US5646027A (en) * 1994-09-08 1997-07-08 Warner-Lambert Company Process for the production of gelatinase catalytic domain protein
RU2142958C1 (ru) * 1997-12-25 1999-12-20 Товарищество с ограниченной ответственностью "Верта" Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
JP2004508801A (ja) 1999-10-29 2004-03-25 カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ ナイセリア抗原性ペプチド

Also Published As

Publication number Publication date
NO20034146D0 (no) 2003-09-17
ZA200405328B (en) 2006-03-29
CA2472775A1 (en) 2003-07-31
JP2005515262A (ja) 2005-05-26
US20030139345A1 (en) 2003-07-24
PL209827B1 (pl) 2011-10-31
NZ533738A (en) 2006-03-31
PL371254A1 (en) 2005-06-13
HRP20040732A2 (en) 2005-06-30
ES2324027T3 (es) 2009-07-29
LV13289B (en) 2005-11-20
NO20034146L (no) 2003-10-28
DE60326539D1 (de) 2009-04-23
IL162714A0 (en) 2005-11-20
ATE425247T1 (de) 2009-03-15
RU2004125599A (ru) 2005-07-10
LV13419B (en) 2006-09-20
RU2346043C2 (ru) 2009-02-10
US8012935B2 (en) 2011-09-06
YU76403A (sh) 2006-05-25
KR20040077764A (ko) 2004-09-06
CN101007844A (zh) 2007-08-01
EP1468085B1 (en) 2009-03-11
EP1468085A1 (en) 2004-10-20
WO2003062413A1 (en) 2003-07-31
BR0302819A (pt) 2004-04-27
MXPA04007170A (es) 2004-10-29
CN1622992A (zh) 2005-06-01

Similar Documents

Publication Publication Date Title
ATE477020T1 (de) Prevention und verringerung von ischemia
CO6241137A2 (es) Antagonistas ciclicos de peptido cxcr4
MXPA04001033A (es) Compuesto de sanado para heridas y anti-cancer.
NO20041700L (no) Human koagulasjonsfaktor VII-polypeptider
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
FR2842209B1 (fr) Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
MX2008009493A (es) Peptido novedoso y uso del mismo.
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
EE200400030A (et) Sünteetiline oligopeptiid, selle kasutamine maatriksmetalloproteinaasi aktiivsuse pärssimiseks ningvähkkasvaja invasiooni ja metastaaside ärahoidmiseks ja ravimiseks
RU2014134287A (ru) Бифункциональный пептид
Becker et al. New substrate analogue furin inhibitors derived from 4-amidinobenzylamide
BR0113147A (pt) Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
Łęgowska et al. Peptomeric analogues of trypsin inhibitor SFTI-1 isolated from sunflower seeds
LT2004079A (en) Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
Basse et al. Development of lipopeptides for inhibiting 20S proteasomes
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
ATE544779T1 (de) Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
ES2353479T3 (es) Moduladores de il-32.
WO2002053172A3 (en) Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover
DE50310131D1 (de) Peptide mit hohem cysteingehalt
AU2003205658A1 (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
ATE305478T1 (de) Topoisomerase-ii inhibitoren